SCHEMBL4811124

SCHEMBL4811124

COC(=O)[C@H](COC(C)=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
GLS O94925 1/20 0.49
ALDH1A1 P00352 3/20 0.46
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
MEN1 O00255 2/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PKM P14618 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811129 1.00 KMT2A (0.55) KMT2AGLSALDH1A1PTGS1PTGS2
SCHEMBL27935006 0.86 ALDH1A1 (0.48) KMT2AGLSALDH1A1CYP3A4PKM
SCHEMBL8460020 0.86 CYP2C19 (0.49) KMT2AGLSALDH1A1CYP3A4PKM
SCHEMBL819828 0.86 KMT2A (0.58) KMT2AGLSALDH1A1PTGS1PTGS2
SCHEMBL8208998 0.83 KMT2A (0.51) KMT2AALDH1A1PTGS1PTGS2ESR1
SCHEMBL28062414 0.83 EPHX1 (0.54) KMT2AGLSALDH1A1CYP3A4PKM
SCHEMBL22418886 0.83 GLS (0.46) KMT2AGLSALDH1A1MEN1CYP3A4
Hydrochloric Acid SCHEMBL8484874 0.81 KMT2A (0.53) KMT2AGLSALDH1A1ESR1ESR2
SCHEMBL820937 0.81 KMT2A (0.53) KMT2AALDH1A1ESR1ESR2MEN1
SCHEMBL13175572 0.81 KMT2A (0.56) KMT2AGLSALDH1A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008149110-A1 BICYCLOR [2.2.1] HEPT-7-YLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES AND CONDITIONS IN WHICH M3 MUSCARINIC RECEPTOR ACTIVITY AND BETA-ADRENERGIC ACTIVITY ARE IMPLICATED ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 WO disclosed
WO-2008096129-A1 NITROGEN CONTAINING HETROCYCLIC COMPOUNDS USEFUL AS BIFUNCTIONAL MODULATORS OF M3 RECEPTORS AND BETA- 2 RECEPTORS ARGENTA DISCOVERY LTD (GB) 2008-08-14 WO disclosed